(155) investigated the efficacy of OXA and anti-PD-L1 drugs in a microsyngeneic transplantation mouse model based on the CT26 cell line and found that the combination therapy of OXA and anti-PD-L1 drugs significantly slowed tumor growth compared to the use of OXA alone (191). This evidence concerns the gene CD274 and neoplasm.